[Precocious menopause after antimitotic therapy. Is in vitro fertilization with oocyte donation the only appropriate response?]

Contracept Fertil Sex. 1997 Jul-Aug;25(7-8):647-53.
[Article in French]

Abstract

Advances in antimitotic treatments have improved the prognosis of cancer in young subjects. The resulting increase in life expectancy raises the question of the subject's future fertility, a question that should be posed before beginning any anticancer therapy which could lead to a gonadal failure. If oocyte donation remains the alternative indication proposed for these patients desiring a child, it is important to assess the tissue alterations in the uterus, to verify its vascularization under suitable treatment and appreciate the other alternative directions.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Estrogen Replacement Therapy
  • Female
  • Fertilization in Vitro*
  • Humans
  • Infertility, Female / chemically induced*
  • Infertility, Female / therapy*
  • Life Expectancy
  • Menopause, Premature / drug effects*
  • Oocyte Donation*
  • Patient Selection*
  • Pregnancy
  • Pregnancy Outcome
  • Uterus / blood supply

Substances

  • Antineoplastic Agents